Zobrazeno 1 - 10
of 84
pro vyhledávání: '"clinically important deterioration"'
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 2225-2243 (2023)
Gian Marco Manzetti,1 Josuel Ora,1 Arianna Sepiacci,1 Mario Cazzola,1 Paola Rogliani,1 Luigino Calzetta2 1Department of Experimental Medicine, Unit of Respiratory Medicine, University of Rome “Tor Vergata”, Rome, Italy; 2Department of Medicine an
Externí odkaz:
https://doaj.org/article/74c00e6692ff4ce597355232e3d21181
Autor:
Qing Song, Aiyuan Zhou, Ling Lin, Xueshan Li, Wei Cheng, Cong Liu, Yating Peng, Yuqin Zeng, Rong Yi, Yi Liu, Xin Li, Yan Chen, Shan Cai, Ping Chen
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: This study aimed to analyze the clinical characteristics and treatment response of patients with chronic obstructive pulmonary disease (COPD) with low body mass index (BMI).Methods: In this cross-sectional study, we enrolled patients with
Externí odkaz:
https://doaj.org/article/b0b23668ec6c49dcba76e475b2cc3054
Autor:
Vogelmeier CF, Naya IP, Maltais F, Bjermer L, Kerwin EM, Tombs L, Jones PW, Compton C, Lipson DA, Boucot IH
Publikováno v:
International Journal of COPD, Vol Volume 16, Pp 1215-1226 (2021)
Claus F Vogelmeier,1 Ian P Naya,2,3 François Maltais,4 Leif Bjermer,5 Edward M Kerwin,6 Lee Tombs,7 Paul W Jones,2 Chris Compton,2 David A Lipson,8,9 Isabelle H Boucot2,10 1Department of Medicine, Pulmonary and Critical Care Medicine, University Med
Externí odkaz:
https://doaj.org/article/82871598f9d44481b1c3321d8c09421a
Autor:
Yuki Abe, Masaru Suzuki, Hironi Makita, Hirokazu Kimura, Kaoruko Shimizu, Satoshi Konno, Masaharu Nishimura
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with a complex progression of many clinical presentations, and clinically important deterioration (CID) has been proposed in the Western studies as a composit
Externí odkaz:
https://doaj.org/article/317182f5a6c048df9fe13ab108506b08
Publikováno v:
International Journal of COPD, Vol Volume 15, Pp 3375-3384 (2020)
Wen-Chien Cheng,1– 6 Biing-Ru Wu,1,3,5,6 Wei-Chih Liao,1,2,4,7 Chih-Yu Chen,1 Wei-Chun Chen,1,3– 6 Te-Chun Hsia,1,4,8 Chih-Yen Tu,1– 3 Chia-Hung Chen,1,2,7 Wu-Huei Hsu1 1Division of Pulmonary and Critical Care Medicine, Department of Internal M
Externí odkaz:
https://doaj.org/article/616ab099b3954515b1b11c989b06a5d1
Publikováno v:
International Journal of COPD, Vol Volume 15, Pp 2309-2318 (2020)
Edward M Kerwin,1 Lindsey Murray,2 Xiaoli Niu,3 Carole Dembek3 1Clinical Research Institute of Southern Oregon, Medford, OR, USA; 2Evidera, Bethesda, MD, USA; 3Sunovion Pharmaceuticals Inc., Marlborough, MA, USACorrespondence: Xiaoli NiuSunovion Phar
Externí odkaz:
https://doaj.org/article/6f0be7444b8d4856b9d730d559acc858
Autor:
Dave Singh, Gerard J. Criner, Ian Naya, Paul W. Jones, Lee Tombs, David A. Lipson, MeiLan K. Han
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-13 (2020)
Abstract Given the heterogeneity of chronic obstructive pulmonary disease (COPD), personalized clinical management is key to optimizing patient outcomes. Important treatment goals include minimizing disease activity and preventing disease progression
Externí odkaz:
https://doaj.org/article/92a883a1fd144981937dfeb59dc62e36
Autor:
Fernando J. Martinez, Brian J. Lipworth, Klaus F. Rabe, David J. Collier, Gary T. Ferguson, Sanjay Sethi, Gregory J. Feldman, Gerald O’Brien, Martin Jenkins, Colin Reisner
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-14 (2020)
Abstract Background The Phase III PINNACLE studies assessed the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI), a dual long-acting bronchodilator for chronic obstructive pulmonary disease (COPD). Here we pres
Externí odkaz:
https://doaj.org/article/1fab64b709184230bb45b23bc67e6cfe
Autor:
Mona Bafadhel, Dave Singh, Christine Jenkins, Stefan Peterson, Thomas Bengtsson, Peter Wessman, Malin Fagerås
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Background Clinically Important Deterioration (CID) is a novel composite measure to assess treatment effect in chronic obstructive pulmonary disease (COPD). We examined the performance and utility of CID in assessing the effect of inhaled co
Externí odkaz:
https://doaj.org/article/fb9709e22f4446eb9d72fff30ed2d662
Autor:
François Maltais, Leif Bjermer, Edward M. Kerwin, Paul W. Jones, Michael L. Watkins, Lee Tombs, Ian P. Naya, Isabelle H. Boucot, David A. Lipson, Chris Compton, Mitra Vahdati-Bolouri, Claus F. Vogelmeier
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-15 (2019)
Abstract Background Prospective evidence is lacking regarding incremental benefits of long-acting dual- versus mono-bronchodilation in improving symptoms and preventing short-term disease worsening/treatment failure in low exacerbation risk patients
Externí odkaz:
https://doaj.org/article/4397ec211a684a41994894718e1f28f9